University of Arkansas, Fayetteville
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Arkansas, Fayetteville sits in the top decile of US sponsors by registered trial count (#626 of 15,742 sponsors by registered trial count).
University of Arkansas, Fayetteville: 25 sponsored US clinical trials, 7 recruiting.
University of Arkansas, Fayetteville sponsors 25 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 16 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Polycystic Ovary Syndrome (PCOS), with 2 trials.
Top-decile sponsor footprint
University of Arkansas, Fayetteville ranks in the top decile of sponsors by registered trial count (#626 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
16 of 16 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
25 total, page 1 of 1
Appetite Response to Meals With Different Protein Sources in Women With PCOS
NCT07142603
Protein and Polycystic Ovary Syndrome (PCOS)
NCT07158723
The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder
NCT06115603
Targeting Components of Distress Tolerance
NCT06570603
Protein and Exercise for Postmenopausal Women's Wellbeing
NCT06849817
Time Restricted Feeding, Muscle, and Metabolism
NCT04949451
Neural Enabled Prosthesis for Upper Limb Amputees
NCT03432325
Diet, Food, Exercise and Nutrition During Social Distancing
NCT04754074
Diet and Health in Adults With Metabolic Syndrome
NCT03935048
Methods of Assessing Sweat-Electrolyte Testing (MAST)
NCT07490756
Comparison Between a Live Canine or Toy Dog on Prosocial Behavior and Emotional Regulation in Autistic Children
NCT06915415
Animal-Assisted Therapy in Pediatric Autism Spectrum Disorders
NCT06687850
The Effect of Water With Anti-Inflammatory Capabilities on the Inflammatory Response to Heavy Resistance Exercise
NCT07456683
Evaluation of Sports Supplements on Blood Flow
NCT04278053
Nutrition, Body Composition, and Sleep
NCT03603041
Breakfast and Muscle Health in Children
NCT03602144
Breakfast and Metabolism in Men
NCT03399812
Diet, Nutrient Status, and Food Insecurity
NCT03412825
Impact of Cranberry Juice Consumption on Gut and Vaginal Microbiota in Post-menopausal Women
NCT04680325
Breakfast and Energy Expenditure in Young Women
NCT03079635
The Role of Hydration on Exercise Performance - ODIN
NCT02980939
Nutrition Intervention to Measure Metabolic Response in Children
NCT03139773
The Effect of Vasopressin on Glucose Regulation
NCT02761434
Protein Source, Nutrition Messaging, and Food Intake
NCT03083145
Evaluating the Relationship Between Tobacco Use, Anxiety Sensitivity, and Panic in Adolescents
NCT00535964
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
What is open in the University of Arkansas, Fayetteville pipeline
7 recruiting of 25 indexed (28% open); 16 completed (64%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Polycystic Ovary Syndrome (PCOS) (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Arkansas, Fayetteville: open-pipeline peers nationwide
Peers matched on 25 registered trials and 28% open enrollment, not the therapeutic-area sidebar.
University of Arkansas, Fayetteville sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 25 trials (± recruiting share)
- Arcus Biosciences · 25 trials · 12% recruiting
- Arcutis Biotherapeutics · 25 trials · 8% recruiting
- Ardelyx · 25 trials · 12% recruiting
- Drexel University College of Medicine · 25 trials · 0% recruiting
Sponsors near 28% open enrollment (± trial volume)
- Hanmi Pharmaceutical Company Limited · 28% recruiting · 25 trials
- The University of Texas at Dallas · 28% recruiting · 50 trials
- Merit Medical Systems · 28% recruiting · 18 trials
- 89bio · 29% recruiting · 7 trials
Related
What to do with this University of Arkansas, Fayetteville page
25 registered trials is a research-attention snapshot, not an endorsement of University of Arkansas, Fayetteville or any single study.
- 7 of University of Arkansas, Fayetteville's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Polycystic Ovary Syndrome (PCOS) is the condition University of Arkansas, Fayetteville studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Polycystic Ovary Syndrome (PCOS) trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Arkansas, Fayetteville pipeline card: 25 registered trials from official public datasets.Report a data error.